Medical Devices APAC

APAC Neurology Devices Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

APAC Neurology Devices Market Industry Trends and Forecast to 2034: Segmented by (Product, Application, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $3.03 Bn Placeholder estimate
Estimate 2025 $3.35 Bn 23.5% of the global market
Projected 2034 $8.23 Bn 145.6% Adds $4.88 Bn over 9 forecast years
CAGR 2025–2034 10.5% Faster than 57% of 180 Medical Devices markets here
Key players 6 +1
  • APAC is 23.51% of the global market.
  • Among regions, the largest is North America at $7.91 Bn.
  • Fastest growing: APAC (this report) at 10.5% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.88 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Neurology Devices Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $3.03 Bn — —
2025 (base) $3.35 Bn +$318.6 Mn —
2026 (forecast) $3.70 Bn +$352.0 Mn +10.5%
2027 (forecast) $4.09 Bn +$389.0 Mn +22.1%
2028 (forecast) $4.52 Bn +$429.8 Mn +34.9%
2029 (forecast) $5.00 Bn +$475.0 Mn +49.1%
2030 (forecast) $5.52 Bn +$524.8 Mn +64.7%
2031 (forecast) $6.10 Bn +$579.9 Mn +82%
2032 (forecast) $6.74 Bn +$640.8 Mn +101.2%
2033 (forecast) $7.45 Bn +$708.1 Mn +122.3%
2034 (forecast) $8.23 Bn +$782.5 Mn +145.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC Neurology Devices Market Analysis at a glance
Market size, 2025$3.35 Bn placeholder estimate
Forecast, 2034$8.23 Bn placeholder estimate
Growth (CAGR), 2025–203410.5% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, application and end user (see all)
Key playersMedtronic, Boston Scientific Corporation, Abbott Laboratories, Stryker, Integra Life Sciences Corporation and 1 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC Neurology Devices Market Analysis Executive Summary

Neurology devices diagnose and treat diseases of the brain, spine and nerves, such as stimulators, monitors and shunts.

Key segments of the neurology devices market include product (Neurostimulators, Neurovascular Devices and Cerebrospinal Fluid Management) and application (Epilepsy, Parkinson's Disease and Chronic Pain).

Bar chart: Asia Pacific Neurology Devices market size, 2024–2034, placeholder estimates. $3.03 Bn in 2024, $3.35 Bn in 2025 and $8.23 Bn in 2034, 10.5% CAGR.
Asia Pacific Neurology Devices market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC Neurology Devices Market Dynamics

Market Growth Drivers

An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the neurology devices market.

Opportunity

Smart implants, less invasive techniques and growing access to surgery in emerging economies give the neurology devices market room to grow.

Market Restraints

Strict approval rules, price pressure from hospital buyers and shortages of trained surgeons in some regions hold back the neurology devices market.

Competitive Landscape for Neurology Devices Market in APAC

The neurology devices market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Neurology Devices Market in APAC

Neurology Devices in APAC: rules and payment

In some of the countries we cover here, medical devices are regulated by TGA (Australia)⁠[1], NMPA (China)⁠[2], MDACS (Hong Kong)⁠[3], CDSCO (India)⁠[4], PMDA (Japan)⁠[5], MDA (Malaysia)⁠[6], Medsafe (WAND) (New Zealand)⁠[7], FDA Philippines (Philippines)⁠[8], HSA (Singapore)⁠[9], Thai FDA (Thailand)⁠[10], Ministry of Health (Indonesia)⁠[11], DRAP (Pakistan)⁠[12], MFDS (South Korea)⁠[13] and Ministry of Health (Vietnam)⁠[14]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[15], basic medical insurance (China)⁠[16], the Hospital Authority (Hong Kong)⁠[17], Ayushman Bharat PM-JAY (India)⁠[18], public health insurance (Japan)⁠[19], subsidised public care (Malaysia)⁠[20], Pharmac (New Zealand)⁠[21], PhilHealth (Philippines)⁠[22], MediShield Life (Singapore)⁠[23], the Universal Coverage Scheme (Thailand)⁠[24], JKN (BPJS Kesehatan) (Indonesia)⁠[25], out of pocket and Sehat Sahulat (Pakistan)⁠[26], National Health Insurance (South Korea)⁠[27] and social health insurance (Vietnam)⁠[28].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Medical Device Division, Department of Health. Checked 14 Nov 2026.

[4] Central Drugs Standard Control Organisation. Checked 14 Nov 2026.

[5] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[6] Medical Device Authority. Checked 14 Nov 2026.

[7] Medsafe. Checked 14 Nov 2026.

[8] Food and Drug Administration Philippines. Checked 14 Nov 2026.

[9] Health Sciences Authority. Checked 14 Nov 2026.

[10] Thai Food and Drug Administration. Checked 14 Nov 2026.

[11] Ministry of Health of Indonesia. Checked 19 Nov 2026.

[12] Drug Regulatory Authority of Pakistan (DRAP). Checked 19 Nov 2026.

[13] Ministry of Food and Drug Safety. Checked 19 Nov 2026.

[14] Ministry of Health of Vietnam. Checked 19 Nov 2026.

[15] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[16] National Healthcare Security Administration. Checked 14 Nov 2026.

[17] Hospital Authority. Checked 14 Nov 2026.

[18] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[19] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[20] Ministry of Health Malaysia. Checked 14 Nov 2026.

[21] Pharmac. Checked 14 Nov 2026.

[22] PhilHealth. Checked 14 Nov 2026.

[23] CPF Board, MediShield Life. Checked 14 Nov 2026.

[24] National Health Security Office. Checked 14 Nov 2026.

[25] BPJS Kesehatan. Checked 19 Nov 2026.

[26] Ministry of National Health Services, Regulations and Coordination. Checked 19 Nov 2026.

[27] Health Insurance Review and Assessment Service (HIRA). Checked 19 Nov 2026.

[28] Vietnam Social Security. Checked 19 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how neurology devices products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in APAC.

Public data, with sources

Neurology Devices in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Neurology Devices market in Asia Pacific?
Placeholder estimate: about $3.35 Bn in 2025, rising to about $8.23 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Neurology Devices market in Asia Pacific growing?
Placeholder estimate: about 10.5% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Neurology Devices market report cover?
The report splits the market by product (Neurostimulators, Neurovascular Devices, Cerebrospinal Fluid Management, Neuromonitoring and more), application (Epilepsy, Parkinson's Disease, Chronic Pain, Stroke and more) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Neurology Devices market?
Key players include Medtronic, Boston Scientific Corporation, Abbott Laboratories, Stryker, Integra Life Sciences Corporation and Nihon Kohden Corporation.
What is driving the Neurology Devices market?
An ageing population, more chronic disease, a rise in elective procedures and steady advances in implants and instruments are driving the neurology devices market.
Back to Catalogue

Related Medical Devices reports in APAC

See all

Related on brain and nerves and stroke

See the topic